TrialRadiation oncology (London, England)2023

Thyroid V40 is a good predictor for subclinical hypothyroidism in patients with nasopharyngeal carcinoma after intensity modulated radiation therapy: a randomized clinical trial.

Yun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.